Data from the literature have shown that CFRD and type 2 diabetes mellitus (T2DM) have overlapping etiology and pathophysiological mechanisms, mainly represented by impaired pancreatic β cells with decreased insulin secretion, rather than decreased insulin sensitivity. The gene discussed is INS; the disease is cystic fibrosis-related diabetes.